I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 29% ± 5% | |
| dendritic cell | 3 studies | 26% ± 8% | |
| endothelial cell | 3 studies | 18% ± 2% | |
| oligodendrocyte | 3 studies | 17% ± 0% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 29% ± 5% | |
| dendritic cell | 3 studies | 26% ± 8% | |
| endothelial cell | 3 studies | 18% ± 2% | |
| oligodendrocyte | 3 studies | 17% ± 0% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 24% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 2522.90 | 21 / 21 | 100% | 20.26 | 504 / 504 |
| esophagus | 100% | 2091.63 | 1445 / 1445 | 100% | 23.48 | 183 / 183 |
| lung | 100% | 2199.64 | 578 / 578 | 100% | 23.91 | 1155 / 1155 |
| ovary | 100% | 2522.01 | 180 / 180 | 100% | 23.54 | 430 / 430 |
| pancreas | 100% | 1655.58 | 328 / 328 | 100% | 18.64 | 178 / 178 |
| uterus | 100% | 2762.62 | 170 / 170 | 100% | 26.01 | 459 / 459 |
| breast | 100% | 2645.07 | 459 / 459 | 100% | 25.24 | 1117 / 1118 |
| brain | 100% | 2051.14 | 2638 / 2642 | 100% | 24.57 | 705 / 705 |
| prostate | 100% | 2626.36 | 245 / 245 | 100% | 19.28 | 501 / 502 |
| thymus | 100% | 3072.49 | 653 / 653 | 100% | 26.01 | 603 / 605 |
| intestine | 100% | 2492.45 | 966 / 966 | 100% | 17.85 | 525 / 527 |
| stomach | 100% | 2112.11 | 359 / 359 | 99% | 17.16 | 283 / 286 |
| kidney | 100% | 2324.31 | 89 / 89 | 99% | 18.76 | 891 / 901 |
| skin | 100% | 2788.77 | 1809 / 1809 | 99% | 27.60 | 466 / 472 |
| adrenal gland | 100% | 2126.37 | 258 / 258 | 97% | 16.38 | 222 / 230 |
| liver | 100% | 1203.27 | 226 / 226 | 95% | 10.54 | 386 / 406 |
| adipose | 100% | 2659.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2664.27 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 26.29 | 29 / 29 |
| muscle | 100% | 2736.59 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2987.41 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 29.89 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.18 | 1 / 1 |
| heart | 98% | 1555.46 | 846 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 18.71 | 78 / 80 |
| peripheral blood | 90% | 1507.83 | 839 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045665 | Biological process | negative regulation of neuron differentiation |
| GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005634 | Cellular component | nucleus |
| Gene name | NEPRO |
| Protein name | Nucleolus and neural progenitor protein |
| Synonyms | C3orf17 |
| Description | FUNCTION: May play a role in cortex development as part of the Notch signaling pathway. Downstream of Notch may repress the expression of proneural genes and inhibit neuronal differentiation thereby maintaining neural progenitors. May also play a role in preimplentation embryo development. . |
| Accessions | ENST00000383675.6 [Q6NW34-2] F8WC60 ENST00000496206.5 ENST00000472705.5 ENST00000473284.5 ENST00000496340.1 E9PFF8 ENST00000460410.5 ENST00000489848.5 C9J9E3 ENST00000469809.5 ENST00000314400.10 [Q6NW34-1] ENST00000469169.5 F8WDL7 ENST00000461381.5 F8WBQ8 ENST00000470663.1 ENST00000491121.1 F2Z3E4 ENST00000472166.1 ENST00000494164.5 ENST00000462295.5 ENST00000472637.5 Q6NW34 |
